Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently been diagnosed with acute myeloid leukemia (a type of blood cancer).
- People who are 18 years old or younger.
- People who are able to sign a written consent form agreeing to take part.
Who may not be able to join:
- People who would be unable to follow the study requirements and attend as needed.
- People with serious heart problems (where the heart is pumping at less than 50% of normal capacity), serious liver problems (based on specific blood test results being too high), or serious kidney problems (based on a specific kidney marker in the blood being too high).
- People who have a severe active infection at the time of joining.
- People who have other health conditions that would make it unsafe for them to receive chemotherapy (cancer-fighting medication) or a transplant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8610-88325949
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary end point was cumulative incidences of relapse (CIR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.